H. Gadner

936 total citations
39 papers, 608 citations indexed

About

H. Gadner is a scholar working on Surgery, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Gadner has authored 39 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Neurology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Gadner's work include Neuroblastoma Research and Treatments (9 papers), Testicular diseases and treatments (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). H. Gadner is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Testicular diseases and treatments (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). H. Gadner collaborates with scholars based in Austria, Germany and United States. H. Gadner's co-authors include H. Riehm, E. Odenwald, Gabriele Calaminus, U. Göbel, J.P.M. Bökkerink, J. Engert, G. Henze, K.-L. Waag, D. Harms and C. Teske and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

H. Gadner

38 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Gadner Austria 13 259 233 147 145 106 39 608
H. Spaar Germany 13 139 0.5× 268 1.2× 155 1.1× 143 1.0× 89 0.8× 35 548
Burgert Eo United States 12 104 0.4× 159 0.7× 92 0.6× 105 0.7× 201 1.9× 26 499
B. Pellegrino France 11 114 0.4× 118 0.5× 192 1.3× 69 0.5× 77 0.7× 22 565
J.C. Gentet France 11 84 0.3× 148 0.6× 61 0.4× 99 0.7× 132 1.2× 20 614
Gilchrist Gs United States 12 100 0.4× 152 0.7× 107 0.7× 84 0.6× 132 1.2× 16 425
R. Gopal India 12 61 0.2× 204 0.9× 137 0.9× 95 0.7× 43 0.4× 58 467
Susan Russell Australia 12 89 0.3× 94 0.4× 158 1.1× 95 0.7× 39 0.4× 26 426
Margherita Lo Curto Italy 11 236 0.9× 90 0.4× 50 0.3× 54 0.4× 63 0.6× 16 437
Mary Bergin Australia 11 62 0.2× 189 0.8× 74 0.5× 228 1.6× 49 0.5× 22 511
Annalisa Serra Italy 14 86 0.3× 60 0.3× 134 0.9× 62 0.4× 102 1.0× 47 520

Countries citing papers authored by H. Gadner

Since Specialization
Citations

This map shows the geographic impact of H. Gadner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gadner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gadner more than expected).

Fields of papers citing papers by H. Gadner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gadner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gadner. The network helps show where H. Gadner may publish in the future.

Co-authorship network of co-authors of H. Gadner

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gadner. A scholar is included among the top collaborators of H. Gadner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gadner. H. Gadner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thaler, J., Thomas Kühr, Günther Gastl, et al.. (2008). Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie. DMW - Deutsche Medizinische Wochenschrift. 116(19). 721–728.
2.
Möricke, Anja, M Zimmermann, Alfred Reiter, et al.. (2005). Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95. Klinische Pädiatrie. 217(6). 310–320. 80 indexed citations
4.
Dworzak, Michael, G. Fritsch, Georg Mann, & H. Gadner. (2000). Detection of Residual Disease in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia by Comparative Phenotype Mapping: Method and Significance. Leukemia & lymphoma. 38(3-4). 295–308. 19 indexed citations
5.
Fischmeister, Gustav, Volker Witt, G. Fritsch, et al.. (2000). Permanent tunneled silicone central venous catheters for autologous PBPC harvest in children and young adults. Bone Marrow Transplantation. 26(7). 781–786. 8 indexed citations
6.
7.
Göbel, U., Gabriele Calaminus, J. Engert, et al.. (1998). Teratomas in infancy and childhood. Medical and Pediatric Oncology. 31(1). 8–15. 138 indexed citations
8.
Haupt, Riccardo, et al.. (1997). Risk of secondary leukemia after treatment with etoposide VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations. International Journal of Cancer. 71(1). 9–13. 42 indexed citations
9.
Kerbl, Reinhold, Christian Sitzwohl, Herwig Lackner, et al.. (1996). [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].. PubMed. 108(13). 398–403. 3 indexed citations
10.
Kovar, Heinrich, A. Zoubek, & H. Gadner. (1996). A Long Way from Definition of the Molecular Basis to Benefit in the Clinical Management of Ewing Tumours. Oncology Research and Treatment. 19(3). 234–240. 2 indexed citations
11.
Koller, Elisabeth, O. Krieger, Martin Mistrík, et al.. (1995). Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia. Annals of Hematology. 70(2). 75–78. 1 indexed citations
13.
Zoubek, A., et al.. (1993). Ondansetron in the control of chemotherapy-induced and radiotherapy-induced emesis in children with malignancies. Anti-Cancer Drugs. 4(Supplement 2). 17–21. 6 indexed citations
14.
Köller, Ursula, O. A. Haas, W. D. Ludwig, et al.. (1991). Acute megakaryoblastic leukemia a comparison of phenotypic genotypic and clinical features in children and adults. 32. 179. 1 indexed citations
15.
Fink, F. M. & H. Gadner. (1991). [Acute leukemia in childhood].. PubMed. 141(9-10). 190–5. 4 indexed citations
16.
Calaminus, Gabriele, J.P.M. Bökkerink, H. Gadner, et al.. (1991). Die prognostische Bedeutung des Serum α1-Fetoproteins (AFP) bei Kindern und Jugendlichen mit malignen extrakranialen nichttestikulären Keimzelltumoren. Klinische Pädiatrie. 203(4). 246–250. 14 indexed citations
17.
Göbel, U., M. Bamberg, Rainer Haas, et al.. (1989). Nichttestikuläre Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 247–260. 4 indexed citations
18.
Haas, Oskar A., Andreas Chott, Ruth Ladenstein, & H. Gadner. (1987). Poorly differentiated, neuron-specific enolase positive round cell tumor with two translocations t(11;22) and t(21;22). Cancer. 60(9). 2219–2223. 16 indexed citations
19.
Göbel, U., W. Brandeis, H. Gadner, et al.. (1985). Preliminary Results of the GPO-Trial for Treatment of Non-Testicular Germ-Cell Tumors in Children and Adolescents. Oncology Research and Treatment. 8(3). 178–180. 2 indexed citations
20.
Gadner, H., et al.. (1973). [Acute leukemia following exposure to chloramphenicol? Three case reports and review of the literature (author's transl)].. PubMed. 121(9). 590–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026